AR018180A1 - Procedimiento para la preparacion de acidos hidroxamicos - Google Patents
Procedimiento para la preparacion de acidos hidroxamicosInfo
- Publication number
- AR018180A1 AR018180A1 ARP990101598A ARP990101598A AR018180A1 AR 018180 A1 AR018180 A1 AR 018180A1 AR P990101598 A ARP990101598 A AR P990101598A AR P990101598 A ARP990101598 A AR P990101598A AR 018180 A1 AR018180 A1 AR 018180A1
- Authority
- AR
- Argentina
- Prior art keywords
- aryl
- heteroaryl
- alkyl
- alkoxy
- oxaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrane Compounds (AREA)
Abstract
Compuestos de la formula (I), pueden así prepararse, donde: Z es > CH2 o >NR1; Q es alquilo C1-6, arilo C6-10. heteroarilo C2-9, oxiarilo C6-10 alquiloC1-6, oxiarilo C6-10 arilo C6-10, oxiarilo C6-10 heteroarilo C2-9, arilo C6-10 alquilo C1-6, aril C6-10 arilo C6-10, aril C6-10 heteroarilo C2-9, aril C6-10aril C6-10 alquilo C1-6, aril C6-10 aril C6-10 arilo C1-10, aril C6-10 aril C6-10 heteroarilo C2-9, heteroaril C2-9 alquilo C1-6, heteroaril C2-9 arilo C6-10,heteroarilo C2-9heteroarilo C2-9, arilo C6-10 alcoxi C1-6 alquilo C1-6, arilo C6-10 alcoxi C1-6 arilo C6-10, aril C6-10 alcoxi C1-6 heteroarilo C2-9, oxiheteroarilo C2-9 alquilo C1-6, oxiheteroarilo C2-9 arilo C6-10, oxiheteroarilo C2-9 heteroarilo C2-9, heteroaril C2-9 alcoxi C1-6 alquilo C1-6, heteroaril C2-9alcoxi C1-6 arilo C6-10 o heteroaril C2-9 alcoxi C1-6 heteroarilo C2-9; en la que cada radical arilo C6-10 o heteroarilo C2-9 de dichos arilo C6-10,heteroarilo C2-9, oxiarilo C6-10, alquilo C1-6, oxiarilo C6-10, arilo C6-10, oxiarilo C6-10 heteroarilo C2-9, arilo C6-10 alquilo C1-6, arilC6-10 arilo C6-10, aril C6-10 heteroarilo C2-9, aril C6-10 aril C6-10 alquilo C1-6, aril C6-10 aril C6-10 arilo C6-10, aril C6-10 aril C6-10 heteroarilo C2-9,heteroaril C2-9 alquilo C1-6, heteroaril C2-9 arilo C6-10, heteroarilo C2-9 heteroarilo C2-9, arilo C6-10 alcoxi C1-6 alquilo C1-6, arilo C6-10 alcoxiC1-6 arilo C6-10, arilo C6-10 alcoxi C1-6 heteroarilo C2-9, oxiheteroarilo C2-9 alquilo C1-6, oxiheteroarilo C2-9 arilo C6-10,oxiheteroarilo C2-9 heteroariloC2-9, heteroaril C2-9 alcoxi C1-6 alquilo C1-6, heteroaril C2-9 alcoxi C1-6 arilo C6-10 o heteroaril C2-9 alcoxi C1-6 heteroarilo C2-9 estáopcionalmente sustituido sobre cualquiera de los átoMs de carbono del anillo capaces de formar un enlace adicional mediante uno o más sustituyentespor anillo independientemente seleccionado entre fluoro, cloro, bromo, alquilo C1-6, alcoxi C1-6, perfluoro alquilo C1-3, perfluoro alcoxi C1-3 y oxiariloC6-10; R1 es hidrogeno, alquilo C1-6, aril C6-10 alquilo C1-6, heteroaril C2-9 alquilo C1-6 o un grupo de formula (II), en la que R1 y R3 son
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8136598P | 1998-04-10 | 1998-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018180A1 true AR018180A1 (es) | 2001-10-31 |
Family
ID=22163686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101598A AR018180A1 (es) | 1998-04-10 | 1999-04-08 | Procedimiento para la preparacion de acidos hidroxamicos |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US6288246B1 (es) |
| EP (1) | EP0949244A3 (es) |
| JP (1) | JPH11343277A (es) |
| KR (1) | KR100329902B1 (es) |
| CN (1) | CN1232023A (es) |
| AP (1) | AP1203A (es) |
| AR (1) | AR018180A1 (es) |
| AU (1) | AU747629B2 (es) |
| BG (1) | BG64154B1 (es) |
| BR (1) | BR9901089A (es) |
| CA (1) | CA2268680A1 (es) |
| CO (1) | CO5070713A1 (es) |
| DZ (1) | DZ2757A1 (es) |
| EA (1) | EA002777B1 (es) |
| EG (1) | EG22263A (es) |
| GT (1) | GT199900046A (es) |
| HR (1) | HRP990105A2 (es) |
| HU (1) | HUP9901041A3 (es) |
| ID (1) | ID23337A (es) |
| IL (1) | IL129328A0 (es) |
| IN (1) | IN192342B (es) |
| IS (1) | IS5019A (es) |
| MA (1) | MA24831A1 (es) |
| NO (1) | NO991672L (es) |
| NZ (1) | NZ335104A (es) |
| OA (1) | OA11031A (es) |
| PA (1) | PA8469301A1 (es) |
| PE (1) | PE20000418A1 (es) |
| PL (1) | PL332450A1 (es) |
| SG (1) | SG125880A1 (es) |
| SK (1) | SK43699A3 (es) |
| TN (1) | TNSN99052A1 (es) |
| TR (1) | TR199900755A2 (es) |
| TW (1) | TW448147B (es) |
| UA (1) | UA57750C2 (es) |
| UY (1) | UY25460A1 (es) |
| YU (1) | YU18199A (es) |
| ZA (1) | ZA992631B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9918684D0 (en) | 1999-08-09 | 1999-10-13 | Novartis Ag | Organic compounds |
| US6458822B2 (en) | 2000-03-13 | 2002-10-01 | Pfizer Inc. | 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases |
| GB0103303D0 (en) | 2001-02-09 | 2001-03-28 | Novartis Ag | Organic compounds |
| WO2004106319A1 (en) * | 2003-05-30 | 2004-12-09 | Pfizer Products Inc. | Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide |
| RU2326862C2 (ru) * | 2003-08-29 | 2008-06-20 | Басф Акциенгезельшафт | Способ получения о-замещенных гидроксиламиновых соединений |
| WO2015094752A1 (en) | 2013-12-18 | 2015-06-25 | Brita Lp | Container for filter-as-you-pour system |
| TW202237119A (zh) | 2020-12-10 | 2022-10-01 | 美商住友製藥腫瘤公司 | Ａｌｋ﹘５抑制劑和彼之用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA794723B (en) | 1978-09-11 | 1980-08-27 | Univ Miami | Anti-hypertensive agents |
| GB9000725D0 (en) | 1990-01-12 | 1990-03-14 | Pfizer Ltd | Therapeutic agents |
| US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| PL331895A1 (en) | 1996-08-23 | 1999-08-16 | Pfizer | Arylosulphonylamino derivatives of hydroxamic acid |
| BR9807815A (pt) | 1997-02-03 | 2000-03-08 | Pfizer Prod Inc | Derivados de ácido arilsulfonilamino-hidroxâmico |
| DK0895988T3 (da) | 1997-08-08 | 2002-09-09 | Pfizer Prod Inc | Arylsulfonylaminohydroxamsyrederivater |
| EA002490B1 (ru) | 1997-08-08 | 2002-06-27 | Пфайзер Продактс Инк. | Производные арилоксиарилсульфониламиногидроксамовой кислоты |
| PA8469401A1 (es) | 1998-04-10 | 2000-05-24 | Pfizer Prod Inc | Derivados biciclicos del acido hidroxamico |
-
1999
- 1999-03-19 PA PA19998469301A patent/PA8469301A1/es unknown
- 1999-03-25 GT GT199900046A patent/GT199900046A/es unknown
- 1999-03-26 EP EP99302343A patent/EP0949244A3/en not_active Withdrawn
- 1999-04-01 SK SK436-99A patent/SK43699A3/sk unknown
- 1999-04-01 OA OA9900074A patent/OA11031A/en unknown
- 1999-04-05 IL IL12932899A patent/IL129328A0/xx unknown
- 1999-04-06 IS IS5019A patent/IS5019A/is unknown
- 1999-04-06 PE PE1999000278A patent/PE20000418A1/es not_active Application Discontinuation
- 1999-04-06 IN IN512DE1999 patent/IN192342B/en unknown
- 1999-04-06 TW TW088105453A patent/TW448147B/zh active
- 1999-04-07 MA MA25526A patent/MA24831A1/fr unknown
- 1999-04-07 CN CN99104834A patent/CN1232023A/zh active Pending
- 1999-04-07 TN TNTNSN99052A patent/TNSN99052A1/fr unknown
- 1999-04-07 UY UY25460A patent/UY25460A1/es not_active Application Discontinuation
- 1999-04-07 DZ DZ990058A patent/DZ2757A1/xx active
- 1999-04-07 ID IDP990307D patent/ID23337A/id unknown
- 1999-04-07 US US09/287,508 patent/US6288246B1/en not_active Expired - Fee Related
- 1999-04-08 YU YU18199A patent/YU18199A/sh unknown
- 1999-04-08 EG EG37399A patent/EG22263A/xx active
- 1999-04-08 SG SG1999001650A patent/SG125880A1/en unknown
- 1999-04-08 AP APAP/P/1999/001503A patent/AP1203A/en active
- 1999-04-08 TR TR1999/00755A patent/TR199900755A2/xx unknown
- 1999-04-08 KR KR1019990012326A patent/KR100329902B1/ko not_active IP Right Cessation
- 1999-04-08 AR ARP990101598A patent/AR018180A1/es not_active Application Discontinuation
- 1999-04-08 CA CA002268680A patent/CA2268680A1/en not_active Abandoned
- 1999-04-08 UA UA99041999A patent/UA57750C2/uk unknown
- 1999-04-09 HU HU9901041A patent/HUP9901041A3/hu unknown
- 1999-04-09 BG BG103319A patent/BG64154B1/bg unknown
- 1999-04-09 PL PL99332450A patent/PL332450A1/xx not_active Application Discontinuation
- 1999-04-09 CO CO99021089A patent/CO5070713A1/es unknown
- 1999-04-09 NZ NZ335104A patent/NZ335104A/xx unknown
- 1999-04-09 HR HR60/081,365A patent/HRP990105A2/hr not_active Application Discontinuation
- 1999-04-09 ZA ZA9902631A patent/ZA992631B/xx unknown
- 1999-04-09 BR BR9901089-5A patent/BR9901089A/pt not_active IP Right Cessation
- 1999-04-09 JP JP11103156A patent/JPH11343277A/ja active Pending
- 1999-04-09 EA EA199900284A patent/EA002777B1/ru not_active IP Right Cessation
- 1999-04-09 AU AU23690/99A patent/AU747629B2/en not_active Ceased
- 1999-04-09 NO NO991672A patent/NO991672L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5080804A1 (es) | Derivados biciclicos del acido hidroxamico | |
| DE69316377D1 (de) | Serotoninrezeptor-mittel | |
| DK0610134T3 (da) | Indolderivater som 5-HT,1-lignende agonister | |
| AR006520A1 (es) | Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion. | |
| EA200100428A1 (ru) | Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты) | |
| FI792005A (fi) | 2-(2-alkoxietyl)-2'-hydroxi-6,7-benzomorfaner deras syraadditionssalter dessa innehaollande laekemedel och foerfarande foer deras framstaellning | |
| SE7508789L (sv) | Forfarande for framstellnign av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner, deras syraadditionssalter och anvendning som lekemedel | |
| NO20015446L (no) | Kinolin-derivater som inhibitorer for MEK-enzymer | |
| SE8104783L (sv) | Heterocykliska foreningar | |
| DK351788A (da) | Tetrahydroisoquinolin-2-ylderivater af carboxylsyrer som thromboxan-a2-antagonister | |
| AR018180A1 (es) | Procedimiento para la preparacion de acidos hidroxamicos | |
| SE7709865L (sv) | Nya fenyletylaminer och forfarande for framstellning derav | |
| YU71496A (en) | Azetidines, their salts, application and process for preparation | |
| EA199800987A1 (ru) | Бензоксазиноновые антагонисты рецептора допамина d4 | |
| NO864516L (no) | Fremgangsmaate for fremstilling av alkyl-beta-carboliner. | |
| YU47219B (sh) | Antivirusna tetrahidroimidazo (1,4) benzodiazepin-2-tiona jedinjenja i postupak za njihovo dobijanje | |
| EA199800233A1 (ru) | Производные 2-циклогексан-1,3-дионбензоила | |
| CO4750814A1 (es) | Nuevos derivados de fenilamidina, su procedimiento para su preparacion y su utilizacion como medicamentos | |
| SE7501365L (es) | ||
| DK182783D0 (da) | Fremgangsmade til fremstilling af 1-carboxy-(alkanoyl eller aralkanoyl)-indolin-2-carboxylsyreestere eller salte deraf | |
| SE7613140L (sv) | Nya racemiska eller optiskt aktiva pyrimidino-(1,2a)-heterocykliska foreningar med antiflogistisk och koagulationshemmande verkan | |
| YU47047B (sh) | Supstituisani 3-amino-2-benzoilcikloheks-2-enoni, postupak za njihovo dobijanje i primena za dobijanje herbicica | |
| NO20062761L (no) | Ny fremgangsmate for fremstilling av 3-fluorinterte quinoliner | |
| SE7513795L (sv) | Forfarande for framstellning av nya cyklopropylmetylamin-dervat | |
| DK156563C (da) | Analogifremgangsmaade til fremstilling af carbacyklinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |